Emerging therapies: Clopidogrel and aspirin [4]

Stroke

Volumn 36, Issue 4, 2005, Pages 707-

  Moussouttas, Michael ^a  

^a SETON HALL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; TICLOPIDINE;

ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN INFARCTION; CLINICAL TRIAL; DIABETES MELLITUS; DRUG EFFICACY; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERTENSION; LETTER; PRIORITY JOURNAL; THROMBOSIS; TREATMENT FAILURE;

EID: 16844384948     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000157951.72934.0b     Document Type: Letter

References (9)

1. Fisher M, Davalos A. Emerging therapies: MATCH and other trials. Stroke. 2004;35:2604-2609.
2. Diener H, Bogousslavsky J, Brass L, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht H. Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high-risk patients (MATCH): a randomized double-blind placebo-controlled trial. Lancet. 2004;364:331-337.
3. Mohr J, Thompson J, Lazar R, Levin B, Sacco R, Furie K, Kistler J, Albers G, Pettigrew L, Adams H, Jackson C, Pullicino P. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2001;345:1444-1451.
4. Gorelick P, Richardson D, Kelly M, Ruland S, Hung E, Harris Y, Kittner S, Leurgans S. Aspirin and ticlopidine for prevention of recurrent stroke in black patients. J Am Med Assoc. 2003;289:2947-2957.
5. Diener H, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. ESPS 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143:1-13.
6. CAPRIE Steering Committee. A randomized blinded trial of Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE). Lancet. 1996;348:1329-1339.
7. The CURE Trial Investigators. Effects of Clopidogrel in Addition to Aspirin in Patients With Acute Coronary Syndromes Without ST-Segment Elevation. N Engl J Med. 2001;345:494-502.
8. Steinhubl S, Berger P, Mann J, Fry E, DeLago A, Wilmer C, Topol E. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. J Am Med Assoc. 2002;288:2411-2420.
9. Antithrombotic Trialists' Collaboration. Collaborative Meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ 2002;324:71-86.